Incyte (INCY) stock and Xencor (XNCR) stock are in focus as jointly developed antibody drug tafasitamab succeeds in a ...

Some cancers may not require immediate treatment, from prostate cancer to thyroid tumors. Medical experts share when ...

Shared decision-making—balancing clinical data with the patient's personal, logistical, and risk-tolerance factors—is ...

Incyte today announced positive topline results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19 ...

Accutane, known generically as isotretinoin, is not simply a strong acne medication. It is a systemic retinoid that ...

The hair follicle is a highly dynamic mini-organ that undergoes cyclic phases of growth, regression, and rest. The anagen ...

As the world observes World Lymphoma Awareness Day on September 15th, it 39;s a timely reminder of the ongoing battle against ...

Trial data on epcoritamab plus rituximab-lenalidomide, a novel CELMoD agent, late-line CAR-T cell therapy, and selecting ...

Dr Kami Maddocks reflects on fresh data, such as the new epcoritamab combo approval, evolving CD19 sequencing data, and ...

Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...

Cycle smart’ fitness classes are encouraging women to align their workouts with their menstrual cycle. Lydia Spencer-Elliott ...

Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...